GLI1 and cancer: Compared to blocking the upstream regulators in the SHH pathway, an advantage of targeting GLI proteins is that these proteins serve as signaling hubs of multiple pathways that are activated in cancer cells, such as the TGF-β, WNT, and SHH pathways.